Update on vertical HIV transmission

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 8, 1998, Pages 637-646

  Groginsky, Elisabeth ^a   Bowdler, Noelle ^a   Yankowitz, Jerome ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Fetal Diagnosis and Treatment Unit

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Disease transmission, vertical; HIV; Human immunodeficiency viruses

Indexed keywords

AMNION FLUID ANALYSIS; BREAST FEEDING; CLINICAL PRACTICE; CORDOCENTESIS; DELIVERY; EPISIOTOMY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOW BIRTH WEIGHT; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK MANAGEMENT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

AMERICAS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; HIV INFECTIONS--TRANSMISSION; LITERATURE REVIEW; MEASUREMENT; NORTH AMERICA; NORTHERN AMERICA; POPULATION; POPULATION CHARACTERISTICS; PREGNANT WOMEN; RECOMMENDATIONS; RESEARCH METHODOLOGY; TESTING; TREATMENT; UNITED STATES; VERTICAL TRANSMISSION; VIRAL DISEASES;

ADULT; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; ZIDOVUDINE;

EID: 0031715635     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. American College of Obstetricians and Gynecologists: Human immunodeficiency virus infections in pregnancy. ACOG Educ Bull 1997;232:1-8
2. Minkoff HL, Henderson C, Mendez H, et al: Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990;163:1598-1604
3. Blanche S, Newell ML, Mayaux MJ, et al: Morbidity and mortality in European children vertically infected by HIV-1: The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;14:442-450
4. Katz VL, Lim W: HIV infection in pregnancy: A review of current developments. NC Med J 1995;56:102-104
5. John GC, Kreiss J: Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev 1996;18: 149-157
6. Tovo P-A, Gabiano C, Tulisso S: Maternal clinical factors influencing HIV-1 transmission. Acta Paediatr (suppl) 1997; 421:52-55
7. Guerina NG: Management strategies for infectious diseases in pregnancy. Semin Perinat 1994;18:305-320
8. Morrison J, Alp NJ: Vertical transmission of human immunodeficiency virus. Q J Med 1997;90:5-12
9. De Rossi A, Ometto L, Mammano F, et al: Vertical transmission of HIV-1: Lack of detectable virus in peripheral blood cells of infected children at birth. Acquired Immune Deficiency Synd 1992;6:1117-1120
10. Mayaux MJ, Blanche S, Rouzioux C, et al: Maternal factors associated with perinatal hiv-1 transmission: The French Cohort Study: 7 years of follow-up observation. J Acquired Immune Deficiency Synd Hum Retrovirol 1995;8:188-194
11. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-1012
12. Phuapradit W, Chaturachinda K, Taneepanichskul S, et al: Serum vitamin A and β-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obstet Gynecol 1996;87:564-567
13. Greenberg BL, Semba RD, Vink PE, et al: Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS 1997;11:325-332
14. Burger H, Kovacs A, Weiser B, et al: Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;14:321-326
15. Mostad SB, Overbaugh J, DeVange DM, et al: Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-927
16. Rodriguez EM, Mofenson LM, Chang BH, et al: Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. J Acquired Immune Deficiency Synd 1996;10:273-282
17. Bulterys M, Landesman S, Burns DN, et al: Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;15:76-82
18. Bobat R, Coovadia H, Coutsoudis A, et al: Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996;15:604-610
19. Nair P, Alger L, Hines S, et al: Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquired Immune Deficiency Synd 1993;6:298-302
20. Mandelbrot L, Mayaux MJ, Bongain A, et al: Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. Am J Obstet Gynecol 1996;175:661-667
21. Peckham C, Gibb D: Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995;333: 298-302
22. Ukwu HN, Graham BS, Lambert JS, et al: Perinatal transmission of Human Immunodeficiency Virus-1 infection and maternal immunization strategies for prevention. Obstet Gynecol 1992;80:458-468
23. Khouri YF, McIntosh K, Cavacini L, et al: Vertical transmission of HIV-1. J Clin Invest 1995;95:732-737
24. European Collaborative Study. Vertical transmission of HIV-1: Maternal immune status and obstetric factors. AIDS 1996;10:1675-1681
25. Pitt J, Brambilla D, Reichelderfer P, et al: Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study. J Infect Dis 1997;175: 567-575
26. Lambert G, Thea DM, Pliner V, et al: Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection: New York City Perinatal HIV Transmission Collaborative Study Group. J Pediatr 1997;130:890-897
27. Minkoff H, Burns DN, Landesman S, et al: The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173:585-589
28. Coll O, Hernandez M, Boucher C, et al: Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;14:26-30
29. Dickover RE, Garratty EM, Herman SA, et al: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA 1996;275:599-605
30. Thea DM, Steketee RW, Pliner V, et al: The effect of maternal viral load on the risk of perinatal transmission of HIV-1: New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 1997;11:437-444
31. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997;3:549-552
32. Mayaux MJ, Dussaix E, Isopet J, et al: Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French Perinatal Cohort Studies. J Infect Dis 1997;175:172-175
33. Connor EM, Sperling RS, Gelber R, et al: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180
34. Frenkel LM, Cowles MK, Shapiro DE, et al: Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 1997;175:971-974
35. Simpson BJ, Shapiro ED, Andiman WA: Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;14:145-152
36. Wilfert CM: Prevention of perinatal transmission of human immunodeficiency virus: A progress report 2 years after completion of AIDS Clinical Trials Group Trial 076. Clin Infect Dis 1996;23:438-441
37. Fiscus SA, Adimora AA, Schoenbach VJ, et al: Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996;275:1483-1488
38. Wiznia AA, Crane M, Lambert G, et al: Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center. JAMA 1996;275:1504-1506
39. Sperling RS, Shapiro DE, Coombs RW, et al: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-1629
40. Melvin AJ, Burchett SK, Watts DH, et al: Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J Acquired Immune Deficiency Synd Hum Retrovirol 1997;14:232-236
41. Aleixo LF, Goodenow MM, Sleasman JW: Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J Pediatr 1997;130:906-914
42. Hammer SM, Squires KE, Hughes MD, et al: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less: Trials Group 320 study team. N Engl J Med 1997;337:725-733
43. Minkoff H, Augenbraun M: Antiretroviral therapy for pregnant women. Am J Obstet Gynecol 1997;176:478-489
44. Tovo P, de Martino M, Gabiano C, et al: Mode of delivery and gestational age influence perinatal hiv-1 transmission. J Acquired Immune Deficiency Synd Hum Retrovirol 1996; 11:88-94
45. Kuhn L, Bobat R, Coutsoudis A, et al: Cesarean deliveries and maternal-infant HIV transmission: Results from a prospective study in South Africa. J Acquired Immune Deficiency Synd Hum Retrovirol 1996;11:478-483
46. Duliege AM, Amos CI, Felton S, et al: Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995;126:625-632
47. Semprini AE, Castagna C, Ravizza M, et al: The incidence of complications after caesarean section in 156 HIV-positive women. Acquired Immune Deficiency Synd 1995;9: 913-917
48. St. Louis M, Kamenga M, Brown C, et al: Maternal factors influencing vertical HIV transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853-2859
49. Kuhn L, Abrams EJ, Matheson PB, et al: Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 1997;11:429-435
50. Landesman SH, Kalish LA, Burns DN, et al: Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334: 1617-1623
51. Kliks SC, Wara DW, Landers DV, et al: Features of HIV-1 that could influence maternal-child transmission. JAMA 1994;272:467-474
52. Ryder RW, Nsa W, Hassig SE, et al: Perinatal transmission of HIV-1 in Zambia. N Engl J Med 1989;320:1637-1642
53. Boyer PJ, Dillon M, Navaie M, et al: Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994;271: 1925-1930
54. Mofenson LM: Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:252-265
55. Kipatrick D, Hague RA, Yap PL, et al: HLA antigen frequencies in children born to HIV-infected mothers. Dis Markers 1991;9:21-26
56. Hutto C, Zhou Y, He J, et al: Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J Virol 1996;70:3589-3598
57. Papaevangelou V, Pollack H, Riguad M, et al: The amount of early p24 antigenemia and not the time of first detection of virus predicts the clinical outcome of infants vertically infected with human immunodeficiency virus. J Infect Dis 1996;173:574-578
58. Zaknun D, Orav J, Kornegay J, et al: Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease: A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children. J Pediatr 1997;130:898-905
59. Shearer WT, Quinn TC, LaRussa P, et al: Viral load and disease progression in infants infected with human immunodeficiency virus type 1: Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337-1342
60. Ruff AJ, Halsey NA, Coberly J, et al: Breast-feeding and maternal-infant transmission of human immunodeficiency virus type 1. J Pediatrics 1992;121:325-329
61. Committee on Pediatric AIDS: Human milk, breastfeeding, and transmission of human immunodeficiency virus in the United States. Pediatrics 1995;96:977-979
62. Van de Perre P: Postnatal transmission of human immunodeficiency virus type 1: The breast-feeding dilemma. Am J Obstet Gynecol 1995;173:483-487
63. Nagelkerke NJ, Moses S, Embree JE, et al: The duration of breastfeeding by HIV-1-infected mothers in developing countries: Balancing benefits and risks: J Acquired Immune Deficiency Synd Hum Retrovirol 1995;8:176-181
64. Ekpini ER, Wiktor SZ, Satten GA, et al: Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire. Lancet 1997;349:1054-1059
65. Contag CH, Ehrnst A, Duda J, et al: Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol 1997;71:1292-1300
66. De Rossi A, Ometto L, Masiero S, et al: Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection. Acta Paediatr (suppl) 1997;421;22-28
67. Mandelbrot L, Brossard Y, Aubin J-T, et al: Testing for in utero human immunodeficiency virus infection with fetal blood sampling. Am J Obstet Gynecol 1996;175:489-493
68. Doran CM: New approaches to using antiretroviral therapy for the management of HIV Infection. Ann Pharmacother 1997;31:228-236
69. Lambert JS, Mofenson LM, Fletcher CV, et al: Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J Infect Dis 1997;175:283-291
70. Bryson YJ: Perinatal HIV-1 transmission: Recent advances and therapeutic interventions. AIDS (suppl 3) 1996;10: S33-S42
71. Gupta GK: Human immunodeficiency virus testing and counseling: Nuts and bolts. Am J Obstet Gynecol 1996;175: 1502-1510
72. Lurie P, Wolfe SM: Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997;337: 853-856